On the other hand, an abnormality or deficiency in UGT1A1 in vivo is strongly correlated with certain diseases (Gilbert syndrome, Crigler-Najjar syndrome, and hyperbilirubinemia), the toxicity of drugs, and the precise therapeutic profile [47]. The gene discussed is UGT1A1; the disease is Hyperbilirubinemia.